GERN 4.08 Geron Corporation
| Range: | 1.64-5.34 | Vol Avg: | 8810876 | Last Div: | 0 | Changes: | -0.01 |
| Beta: | 0.5 | Cap: | 2.61B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed Jul 31 1996 | Empoloyees: | 141 | ||
| CUSIP: | 374163103 | CIK: | 0000886744 | ISIN: | US3741631036 | Country: | US |
| CEO: | Dr. John A. Scarlett M.D. | Website: | https://www.geron.com | ||||
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Stock Details
Positive 0.23
Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage...
businesswire.com·Tue Oct 15 2024
Positive 0.26
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage...
businesswire.com·Thu Sep 19 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow